SY logo

So-Young International (SY) Company Overview

Profile

Full Name:

So-Young International Inc.

Sector:

Healthcare

Industry:

Health Information Services

Country:

China

IPO:

May 2, 2019

Indexes:

Not included

Website:

http://www.soyoung.com

Description:

So-Young International (SY) is a leading online platform in China that connects users with medical and aesthetic services. It offers information, reviews, and booking options for cosmetic procedures, helping people make informed choices about their health and beauty treatments.

Key Details

Price

$0.93

Market Cap

$94.40 M(Small cap)

Last Dividend

$0.06

TTM Dividend Yield

6.46%

Annual Revenue

$211.78 M(+13.09% YoY)

Annual EPS

$0.03(+132.49% YoY)

PE Ratio

18.88

Annual ROE

0.81%

Annual Debt To Equity

0.01

Beta

0.44

Events Calendar

Earnings

Next earnings date:

Mar 20, 2025

Recent quarterly earnings:

Nov 20, 2024

Recent annual earnings:

Mar 20, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Apr 11, 2024
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Sep 23, 24 Citigroup
Neutral
Mar 23, 23 Jefferies
Buy
Mar 22, 23 Citigroup
Buy
Nov 26, 21 Needham
Buy
Mar 23, 21 Needham
Buy
Mar 23, 21 Canaccord Genuity
Buy
Aug 28, 20 Needham
Buy
May 19, 20 Canaccord Genuity
Buy
Mar 24, 20 Needham
Buy
Jun 10, 19 CICC
Buy

Screeners with SY included

Moving average channel strategy
Stocks above SMA 50
Chinese stocks
Stocks cheaper than 1 dollar
Healthcare sector
High payout ratio stocks
All stocks
High yield dividend stocks
Companies with buyback
Stocks with all time high dividends

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.93
SY price is $0.93

Price All-time High

$20.77
SY price is currently -95.53% below its historical high of $20.77

Price Analysts Target

-
SY price consensus analysts' forecast is unknown

Price Today Change

+3.21%
SY price is up +3.21% today

Price YTD Change

+11.92%
SY price is up +11.92% since January 1st

Price 3-Year Change

-52.12%
SY price is down -52.12% over the past 3 years

Market cap

Market Cap

$94.40 M
SY market capitalization is $94.40 million

Market Cap 3-Year Change

-55.72%
SY market capitalization is down -55.72% over the past 3 years

Market Cap All-time High

$2.08 B
SY market capitalization is currently -95.47% below its historical high of $2.08 billion

Market Cap Sector Rank

45.68%
SY market capitalization is higher than 45.68% of companies in Healthcare sector

Technical

Beta

0.44
SY beta is 0.44

200-day SMA

$0.93
SY price is currently -0.20% below its 200-day simple moving average

14-day RSI

45.16
SY 14-day relative strength index is 45.16

30-day Relative Volume

1.33
SY 30-day relative volume is 1.33

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.06
SY last dividend was $0.06 per share, with an ex-dividend date of April 11, 2024

Next Dividend

-
SY next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

-
SY annual dividend per share value is unknown

Annual Dividend Per Share Sector Rank

-
SY annual dividend per share is unknown

Annual Dividend Per Share 1-Year Change

-
SY annual dividend per share 1-year change is unknown

Annual Dividend Per Share 3-Year Change

-
SY annual dividend per share 3-year change is unknown

Dividend yield

Annual Dividend Yield

-
SY annual dividend yield value is unknown

Annual Dividend Yield Sector Rank

-
SY annual dividend yield is unknown

Other

Annual Payout Ratio

-
SY annual payout ratio value is unknown

Annual Dividends Paid

-
SY annual dividends paid value is unknown

Annual FCF

-$4.05 M
SY annual free cash flow is -$4.05 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$211.78 M
SY annual revenue is $211.78 million

Annual Revenue Analysts Estimate

$1.49 B
SY annual revenue is currently -85.74% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+13.09%
SY annual revenue is up +13.09% year-on-year

Annual Revenue Sector Rank

66.08%
SY annual revenue is higher than 66.08% of companies in Healthcare sector

Profit

Annual Gross Profit

$134.82 M
SY annual gross profit is $134.82 million

Annual Gross Margin

63.66%
SY annual gross profit margin is 63.66%

Annual Operating Profit

-$8.63 M
SY annual operating income is -$8.63 million

Annual Operating Margin

-4.08%
SY annual operating profit margin is -4.08%

Annual Net Income

$3.01 M
SY annual net profit is $3.01 million

Annual Net Margin

1.42%
SY annual net profit margin is 1.42%

EPS

Annual EPS

$0.03
SY annual earnings per share is $0.03

Annual EPS Analysts Estimate

$0.36
SY annual earnings per share is currently -91.94% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+132.49%
SY annual earnings per share is up +132.49% year-on-year

Annual EPS Sector Rank

82.56%
SY annual earnings per share is higher than 82.56% of companies in Healthcare sector

ROA & ROE

Annual ROA

0.66%
SY annual return on assets is 0.66%

Annual ROE

0.81%
SY annual return on equity is 0.81%

EBIT & EBITDA

Annual EBIT

-$8.63 M
SY annual earnings before interest & taxes is -$8.63 million

Annual EBITDA

-$2.11 M
SY annual EBITDA is -$2.11 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

18.88
SY price to earnings ratio is 18.88

PE Ratio Sector Rank

35.03%
SY price to earnings ratio is higher than 35.03% of companies in Healthcare sector

PB Ratio

PB Ratio

0.27
SY price to book ratio is 0.27

PB Ratio Sector Rank

21.7%
SY price to book ratio is higher than 21.7% of companies in Healthcare sector

PS Ratio

PS Ratio

0.46
SY price to sales ratio is 0.46

PS Ratio Sector Rank

13.9%
SY price to sales ratio is higher than 13.9% of companies in Healthcare sector

Enterprise value

Enterprise Value

$64.09 M
SY enterprise value is $64.09 million

Enterprise Value Sector Rank

43.1%
SY enterprise value is higher than 43.1% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-15.12
SY EV/EBITDA is -15.12

EV/EBITDA Sector Rank

8.75%
SY EV/EBITDA is higher than 8.75% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.19
SY annual current ratio is 3.19

Annual Quick Ratio

2.97
SY annual quick ratio is 2.97

Leverage

Annual Debt To Equity

0.01
SY annual debt to equity ratio is 0.01

Annual Interest Coverage Ratio

-
SY annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SY piotroski f-score value is unknown

Altman Z-Score

1.32
SY altman z-score is 1.32

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$453.49 M
SY annual total assets is $453.49 million

Annual Non Current Assets

$210.57 M
SY annual long term assets is $210.57 million

Annual Current Assets

$242.92 M
SY annual total current assets is $242.92 million

Annual Cash & Cash Equivalents

$60.11 M
SY annual cash & cash equivalents is $60.11 million

Equity

Annual Book Value

$344.80 M
SY annual book value is $344.80 million

Annual Working Capital

$166.68 M
SY annual working capital is $166.68 million

Liabilities

Annual Total Liabilities

$92.16 M
SY annual total liabilities is $92.16 million

Annual Total Long Term Liabilities

$15.92 M
SY annual total long term liabilities is $15.92 million

Annual Current Liabilities

$76.24 M
SY annual total current liabilities is $76.24 million

Annual Accounts Payable

-
SY annual accounts payable value is unknown

Debt

Annual Total Debt

$20.56 M
SY annual total debt is $20.56 million

Annual Total Debt 1-Year Change

+99.11%
SY annual total debt is up +99.11% year-on-year

Annual Long Term Debt

$12.16 M
SY annual long term debt is $12.16 million

Annual Short Term Debt

$8.40 M
SY annual short term debt is $8.40 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$220.41 M
SY annual total expenses is $220.41 million

Annual Operating Expenses

$143.45 M
SY annual total operating expenses is $143.45 million

Annual Cost Of Goods Sold

$76.95 M
SY annual cost of goods sold is $76.95 million

Annual SGA

$114.68 M
SY annual SGA is $114.68 million

Annual D&A

$6.52 M
SY annual depreciation & amortization is $6.52 million

Annual Interest Expense

-
SY annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$3.18 M
SY annual cash flow from operations is $3.18 million

Annual CFO 1-Year Change

+118.93%
SY annual cash flow from operations is up +118.93% year-on-year

Annual CFI

-$28.64 M
SY annual cash flow from investing activities is -$28.64 million

Annual CFI 1-Year Change

+66.38%
SY annual cash flow from investing activities is up +66.38% year-on-year

Annual CFF

-$14.14 M
SY annual cash flow from financing activities is -$14.14 million

Annual CFF 1-Year Change

-599.06%
SY annual cash flow from financing activities is down -599.06% year-on-year

Free CashFlow

Annual FCF

-$4.05 M
SY annual free cash flow is -$4.05 million

Annual FCF 1-Year Change

+78.82%
SY annual free cash flow is up +78.82% year-on-year

CAPEX

Annual CAPEX

$7.23 M
SY annual capital expenditures is $7.23 million

Annual CAPEX 1-Year Change

+209.39%
SY annual capital expenditures is up +209.39% year-on-year

Institutional Ownership

Similar stocks

ATOS logo
Atossa Therapeutics (ATOS)
ECOR logo
electroCore (ECOR)
CABA logo
Cabaletta Bio (CABA)
TELA logo
TELA Bio (TELA)
ADAG logo
Adagene (ADAG)
Lexeo Therapeutics (LXEO)
VIGL logo
Vigil Neuroscience (VIGL)
ADVM logo
Adverum Biotechnologies (ADVM)
Artiva Biotherapeutics (ARTV)

FAQ

  • What is the ticker symbol for So-Young International?
  • Does So-Young International pay dividends?
  • What sector is So-Young International in?
  • What industry is So-Young International in?
  • What country is So-Young International based in?
  • When did So-Young International go public?
  • Is So-Young International in the S&P 500?
  • Is So-Young International in the NASDAQ 100?
  • Is So-Young International in the Dow Jones?
  • When was So-Young International's last earnings report?
  • When does So-Young International report earnings?

What is the ticker symbol for So-Young International?

The ticker symbol for So-Young International is NASDAQ:SY

Does So-Young International pay dividends?

Yes, So-Young International pays dividends. The last payment was $0.06, with an ex-dividend date on April 11, 2024

What sector is So-Young International in?

So-Young International is in the Healthcare sector

What industry is So-Young International in?

So-Young International is in the Health Information Services industry

What country is So-Young International based in?

So-Young International is headquartered in China

When did So-Young International go public?

So-Young International's initial public offering (IPO) was on May 2, 2019

Is So-Young International in the S&P 500?

No, So-Young International is not included in the S&P 500 index

Is So-Young International in the NASDAQ 100?

No, So-Young International is not included in the NASDAQ 100 index

Is So-Young International in the Dow Jones?

No, So-Young International is not included in the Dow Jones index

When was So-Young International's last earnings report?

So-Young International's most recent earnings report was on Nov 20, 2024

When does So-Young International report earnings?

The next expected earnings date for So-Young International is Mar 20, 2025